Each year about 1.3 million people are killed and another 50 million people are injured on roads worldwide. These road crashes cost countries between 1 and 3 percent of their GDP. Many of these crashes can be prevented by effective countermeasures. This report helps identify the most effective safety countermeasures.
Policy makers need to justify expenditure on road safety in terms of effectiveness, competing for the scarce
Israel has world class-primary care services and should now focus efforts on bringing its hospitals up to the same high international standards, according to the OECD’s Health Care Quality Review of Israel.
English, PDF, 778kb
This project aims to develop guidelines for compiling such estimates of expenditure by disease categories, and age and gender groups under the SHA framework.
This report is an overview of the management of risk due to livestock diseases, a potentially catastrophic type of risk that can have strong external effects given its links to the food chain and to human health. Animal disease, primarily in farmed livestock, has long been a policy concern for food safety reasons and the high economic losses it can engender. The globalisation of trade and human movement, and sensitivities to food
Walking is the most natural form of mobility; however cities have not always evolved to accommodate the needs of pedestrians and walking has in many cases been neglected in the development of transport systems. Improving the pedestrian environment can contribute significantly to meeting the challenges of climate change, air pollution and health.
This report aims to present decision-makers with hard evidence on the important
Aid plays an important role in reducing poverty and inequality, stimulating growth, building capacity, promoting human development and accelerating the achievement of the Millennium Development Goals. Effective aid is critical both to maximise the impact of aid and to achieve long-term, sustainable development.
Aid to the health sector has increased substantially over the last 20 years from USD 5 billion in 1990 to USD 21.8
The review assesses the institutional arrangements and the performance of the Russian health system.
English, Excel, 704kb
The obesity epidemic slowed down in several OECD countries during the past three years. Rates grew less that previously projected, or did not grow at all, according to new data from ten OECD countries. However, rates remain high and social disparities in obesity are unabated.
Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term trend of rapid increases, according to OECD Health Data 2012.
English, PDF, 416kb
Data from OECD Health Data 2012 focusing on key US issues: why is the US health spending so high? Is US health spending higher due to higher prices or higher service provision? (or both?)? Is the quality of care better in the US? What are the trends in key risk factors to health in the US?